Biological cost associated with fosfomycin resistance in Escherichia coli isolates from urinary tract infections;Coste biológico asociado a la resistencia a la fosfomicina en aislamientos de Escherichia coli de orina

Revista Espanola de Quimioterapia

Volumn 20, Issue 2, 2007, Pages 211-215

  Alos J I ^a,b   Garcia Pena P ^a   Tamayo, J ^a  

^a HOSPITAL DE MÓSTOLES   (Spain)

^b HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

Bacterial fitness; Escherichia coli; Fosfomycin; Fosfomycin resistance; Urinary tract infection

Indexed keywords

AMPICILLIN; CEFOTAXIME; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; LACTOSE; NALIDIXIC ACID;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; ESCHERICHIA COLI; FERMENTATION; MICROBIAL GROWTH; NONHUMAN; PHENOTYPE; URINARY TRACT INFECTION;

COLONY COUNT, MICROBIAL; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FERMENTATION; FOSFOMYCIN; HUMANS; LACTOSE; PHENOTYPE; SELECTION (GENETICS); URINARY TRACT INFECTIONS;

EID: 34548207268     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kahan, F.M., Kahan, J.S., Cassidy, P.J., Kropp, H. The mechanism of action of fosfomycin (phosphonomycin). Ann NY Acad Sci 1974; 235: 364-386.
2. Kadner, R.J., Winckler, H.H. Isolation and characterization of mutations affecting the transport of hexose phosphates in Escherichia coli. J Bacteriol 1973; 113: 895-900.
3. Arca, P., Reguera, G., Hardisson, C. Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicentre survey. J Antimicrob Chemother 1997; 40: 393-399.
4. Mendoza, M.C., García, J.M., Llaneza, J., Méndez, F.J., Hardisson, C., Ortiz, J.M. Plasmid-determined resistance to fosfomycin in Serratia marcescens. Antimicrob Agents Chemother 1980; 18: 215-219.
5. Andreu, A., Alós, J.I., Gobernado, M. y cols. Etiología y sensibilidad a los antimicrobianos de los uropatógenos causantes de la infección urinaria baja adquirida en la comunidad. Estudio national multicéntrico. Enferm Infecc Microbiol Clin 2005; 23: 4-9.
6. Kahlmeter, G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: The ECO.SENS Project. J Antimicrob Chemother 2003; 51: 69-76.
7. Martínez, J.L., Baquero, F. Mutation frequencies and antibiotic resistance. Antimicrob Agents Chemother 2000; 44: 1771-1777.
8. Andersson, D.I., Levin, B.R. The biological cost of antibiotic resistance. Curr Opin Microbiol 1999; 2: 489-493.
9. Gordon, D.M., Riley, M.A. A theoretical and experimental analysis of bacterial growth in the bladder. Mol Microbiol 1992; 6: 555-562.
10. Enne, V.I., Bennett, P.M., Livermore, D.M., Hall, L.M. Enhancement of host fitness by the sul2-toding plasmid p9123 in the absence of selective pressure. J Antimicrob Chemother 2004; 53: 958-963.
11. Nilsson, A.I., Berg, O.G., Aspevall, O., Kahlmeter, G., Andersson, D.I. Biological costs and mechanisms of fosfomycin resistance in Escherichia coli. Antimicrob Agents Chemother 2003; 47: 2850-2858.
12. Marchese, A., Gualco, L., Debbia, E.A., Schito, G.C., Schito, A.M. In vitro activity of fosfomycin against gram-negative urinary pathogens and the biological cost of fosfomycin resistance. Int J Antimicrob Agents 2003; 22 (Suppl. 2): 53-59.
13. Björkman, J., Andersson, D.I. The cost of antibiotic resistance from a bacterial perspective. Drug Resist Update 2000; 3: 237-245.
14. Trzcinski, K., Thompson, C.M., Gilbey, A.M., Dowson, C.G., Lipsitch, M. Incremental increase in fitness cost with increased beta-lattam resistance in pneumococci evaluated by competition in an infant rat nasal colonization model. J Infect Dis 2006; 193: 1296-1303.
15. Reynolds, M.G. Compensatory evolution in rifampin-resistant Escherichia coli. Genetics 2000; 156: 1471-1481.
16. Lenski, R.E., Simpson, S.C., Nguyen, T.T. Genetic analysis of a plasmid-encoded, host genotype-specific enhancement of bacterial fitness. J Bacteriol 1994; 176: 3140-3147.